• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research

  2026-07-17

  Capsazepine, a potent TRPV1 ion channel antagonist from APExBIO, unlocks precise control over nociception and apoptosis pathways in neuroscience and oncology research. This guide details hands-on workflows, troubleshooting strategies, and protocol enhancements for robust TRPV1 channel function research.

• AG-120 (Ivosidenib) Workflows: Precision in Mutant IDH1 Rese

  2026-07-17

  AG-120 (Ivosidenib) empowers researchers to target mutant IDH1 with unmatched selectivity, delivering reliable 2-hydroxyglutarate reduction and restored myeloid differentiation in AML models. This article guides you through optimized experimental workflows, troubleshooting strategies, and the impact of CD44-driven metabolic rewiring in advancing AML mutant IDH1 treatment.

• Crizotinib Hydrochloride: Precision ALK Kinase Inhibitor in

  2026-07-16

  Crizotinib hydrochloride empowers researchers to dissect ALK and c-Met-driven signaling in physiologically relevant gastric cancer assembloid models, making it a standout ALK kinase inhibitor for preclinical drug discovery. Its robust performance in patient-derived co-cultures accelerates resistance mechanism studies and optimizes personalized therapy design.

• Medroxyprogesterone Acetate: Optimized Protocols for Reprodu

  2026-07-16

  Leverage Medroxyprogesterone acetate (MPA) for precision-driven workflows in reproductive biology, renal physiology, and neuroendocrine models. This article details robust experimental setups, troubleshooting tactics, and translational insights to maximize the scientific impact of your hormone-centric research.

• Stat3 and NF-κB Drive Fyn Kinase-Induced Neurodegeneration

  2026-07-15

  This study establishes Stat3 as a novel effector downstream of Fyn kinase in dopaminergic neurodegeneration, using a zebrafish in vivo model. It further demonstrates synergistic roles for Stat3 and NF-κB signaling in microglial activation and neuronal loss, providing mechanistic insight relevant to Parkinson’s disease.

• HyperPFU™ High-Fidelity DNA Polymerase: Technical PCR Guidan

  2026-07-15

  HyperPFU™ high-fidelity DNA polymerase addresses the technical challenge of amplifying long, GC-rich, or otherwise complex DNA templates, providing high sequence fidelity and robust amplification for applications where standard polymerases fail. It is optimal for workflows requiring accurate, blunt-ended PCR products, but is not suitable for protocols that require 3'-A overhangs or sticky ends.

• MK-5108 (VX-689): Precision Aurora A Inhibition in Tumor Ass

  2026-07-14

  MK-5108 (VX-689) delivers nanomolar-selective inhibition of Aurora A kinase, enabling high-resolution dissection of cell cycle progression and tumor cell proliferation. This guide translates new insights from retinoblastoma research into actionable experimental workflows with troubleshooting and optimization strategies for advanced oncology research.

• Optimized Sulfaphenazole Sulfonamides for Safer Anti-TB Ther

  2026-07-14

  This study reports the systematic design of sulfaphenazole-derived sulfonamides with potent activity against Mycobacterium tuberculosis and significantly reduced CYP 2C9 inhibition. These findings offer promising candidates for safer tuberculosis regimens with minimized drug-drug interaction risk.

• TPCA-1: Precision IKK-2 Inhibitor Workflows for Inflammation

  2026-07-13

  TPCA-1 empowers inflammation and cell death researchers with nanomolar, highly selective IKK-2 inhibition for dissecting the NF-κB pathway in disease models. Its robust performance in both in vitro and in vivo systems, coupled with workflow flexibility, makes TPCA-1 from APExBIO a gold-standard tool for advanced cytokine and arthritis studies.

• Bedaquiline: Diarylquinoline Antibiotic for TB and Cancer Re

  2026-07-13

  Bedaquiline, a diarylquinoline antibiotic from APExBIO, sets a new benchmark in multi-drug resistant tuberculosis and cancer metabolism studies by targeting bacterial and mitochondrial energy pathways. This article provides actionable workflows, troubleshooting strategies, and contextualizes recent host-directed therapy advances for optimal, reproducible results.

• Strategic P-gp Inhibition: Zosuquidar and the Future of MDR

  2026-07-12

  This article examines the mechanistic and translational potential of Zosuquidar (LY335979) 3HCl as a selective P-glycoprotein inhibitor, drawing on recent evidence—including breakthrough studies on acquired resistance to targeted degraders in cancer. It blends experimental guidance, competitive positioning, and strategic insight for translational researchers seeking to overcome multidrug resistance in oncology.

• Machine Learning Discovers Novel Senolytics for Cancer Resea

  2026-07-10

  The referenced study introduces a cost-effective machine learning approach to identify novel senolytic compounds, validating ginkgetin, periplocin, and oleandrin as potent agents in human cell models. This work highlights AI's transformative role in accelerating early-stage drug discovery and offers new avenues for targeting cellular senescence in cancer and age-related diseases.

• Hesperadin: Precision Aurora B Kinase Inhibition in Mitosis

  2026-07-09

  Hesperadin empowers researchers to dissect mitotic progression and spindle assembly checkpoint dynamics with unmatched specificity. This ATP-competitive Aurora B kinase inhibitor from APExBIO ensures reproducible results and advanced mechanistic insight, making it indispensable for cell cycle and cancer research.

• MitMAB in Endocytosis and Organoid Assays: Applied Protocols

  2026-07-09

  MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide) unlocks new precision in membrane trafficking studies with advanced ISC organoid models. This guide details optimized workflows, troubleshooting, and the latest innovations for dissecting endocytic mechanisms with confidence.

• Hesperadin: Potent Aurora B Kinase Inhibitor for Mitosis Res

  2026-07-08

  Hesperadin is a highly specific ATP-competitive Aurora B kinase inhibitor that disrupts mitotic progression by blocking phosphorylation events essential for chromosome alignment and segregation. Its well-characterized cellular effects and solubility profile make it a preferred reagent for dissecting spindle assembly checkpoint mechanisms and advancing cancer research.

16063 records 1/1071 page Next 12345 下5页 Last page